Platelet Disorders and Treatments
Platelet Disorders and Treatments is a research topic within Hematology. Science Explorer counts 43k research works in it since 1950. 17.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on platelet disorders, thrombosis mechanisms, and related conditions such as immune thrombocytopenic purpura and von Willebrand disease. It covers topics including platelet function, hemostasis, inflammation, megakaryocyte development, and the molecular mechanisms underlying thrombus formation.
- Platelets
- Thrombosis
- Immune Thrombocytopenic Purpura
- von Willebrand Disease
- Hemostasis
- Inflammation
- Megakaryocyte Development
- Thrombus Formation
- Glycoprotein Iba
- Vascular Biology
- Research works
- 43k fractional, since 1950
- In the world top 10%
- 7.5k per year above
- Top-10% rate
- 17.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +12% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Platelet Disorders and Treatments research?
By volume, the United States and China publish the most (1.3k and 843 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.3k works
- 2 China 843 works
- 3 Japan 293 works
- 4 India 265 works
- 5 Germany 260 works
- 6 Italy 231 works
- 7 France 230 works
- 8 United Kingdom 218 works
- 9 Canada 151 works
- 10 Spain 143 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Platelet Disorders and Treatments research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Platelet Disorders and Treatments research, followed by Inserm and Harvard University.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 37 works
- 2 InsermFrance 26 works
- 3 Harvard UniversityUnited States 23 works
- 4 University of PennsylvaniaUnited States 20 works
- 5 Peking UniversityChina 20 works
- 6 Medical University of ViennaAustria 20 works
- 7 McMaster UniversityCanada 20 works
- 8 University of North Carolina at Chapel HillUnited States 19 works
- 9 Versiti Blood Center of WisconsinUnited States 18 works
- 10 Soochow UniversityChina 17 works
Who are the leading researchers in Platelet Disorders and Treatments?
The most-cited researchers publishing on Platelet Disorders and Treatments include Giuseppe Remuzzi, Vivekanand Jha and Valentı́n Fuster.
- 1 Giuseppe Remuzzi Italy 8.1k citations
- 2 Vivekanand Jha India 5.8k citations
- 3 Valentı́n Fuster United States 5.4k citations
- 4 Hagop M. Kantarjian United States 4k citations
- 5 R. Alon Israel 3.9k citations
- 6 Eric Boerwinkle United States 3.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Platelet Disorders and Treatments research done?
The largest centres of Platelet Disorders and Treatments research in 2022–2025 are Beijing (China), Paris (France), London (United Kingdom) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Milwaukee and Hamilton.
Largest cities, 2022–2025
Where it is the local speciality
- MilwaukeeUS · 31.6 works9.7×
- HamiltonCA · 27.2 works8.1×
Location quotient: how much more of its research is in Platelet Disorders and Treatments than the world average.
Where is the best place to study Platelet Disorders and Treatments?
Among universities, judged by research, Medical University of Vienna, McMaster University and Harvard University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Medical University of ViennaAustria | 74.4 | 36.2% | 12.4× | 20 | +2.0% |
| 2 | McMaster UniversityCanada | 56.9 | 25.9% | 7.1× | 20 | +0.5% |
| 3 | Harvard UniversityUnited States | 56.6 | 35.2% | 3.5× | 23 | -5.0% |
| 4 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 56.3 | 15.4% | 7.2× | 37 | +49.2% |
| 5 | University of MilanItaly | 52.9 | 34.1% | 4.5× | 16 | +17.6% |
| 6 | University of TübingenGermany | 49.1 | 31.8% | 5.6× | 11 | -4.7% |
| 7 | University of PennsylvaniaUnited States | 48.3 | 29.7% | 4.2× | 20 | -14.9% |
| 8 | Maastricht UniversityNetherlands | 45.9 | 27.1% | 4.7× | 8 | +36.8% |
| 9 | The University of SydneyAustralia | 45.4 | 34.3% | 2.1× | 11 | +49.2% |
| 10 | Nara Medical UniversityJapan | 44.6 | 11.9% | 36.3× | 13 | +23.6% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Platelet Disorders and Treatments research growing?
Output in 2018–2022 was 12% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Platelet Disorders and Treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.